CSN Login
Members Online: 10

Exciting new antibody targets all cancers, starting with AML; clinical trials at Oxford University and Stanford University

stemcellbuff
Posts: 1
Joined: Nov 2013

The first drug to target a mutation common to all cancers goes to trial soon in the US and UK, Stanford and Oxford. Solid cancers in one trial, AML in the other. Trial headed by stem cell pioneer Irving Weissman of Stanford Univerity.  Many peer reviewed journal papers are mentioned at below link for review. Good luck!

http://www.dddmag.com/articles/2013/10/trial-may-fight-first-common-target-all-human-cancers

GSRon's picture
GSRon
Posts: 1182
Joined: Jan 2013

Hi All..!!  Yes CD47 brings a lot of hope for many kinds of Cancer.  The first human testing was to start this year.. then early next year.. now mid 2014.  Check out this link..  http://stemcell.stanford.edu/CD47/

 

Be Well All..!

 

Ron mRCC

Subscribe with RSS
About Cancer Society

The content on this site is for informational purposes only. It is not a substitute for professional medical advice. Do not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition. Use of this online service is subject to the disclaimer and the terms and conditions.

Copyright 2000-2014 © Cancer Survivors Network